• Decrease Text SizeIncrease Text Size
  • PDF

Relapsing Polychondritis

Relapsing Polychondritis is an auto-immune condition characterized by the body attacking its own cartilage. Polychondritis patients suffer from recurrent relapsing episodes of painful cartilage inflammation. Susceptible areas include ears, nasopharynx, heart valves, and blood vessels. As stated in Annals of Internal Medicine, Relapsing Polychondritis…can be life-threatening and debilitating. Read more…

The disease is life threatening and debilitating. There is no one specific test for identifying Polychondritis and the course of the disease is often unpredictable. Treatment consists of anti-inflammatory medications and immune suppression with corticosteroids. Research is ongoing to evaluate the effects of stem cells on auto-immune conditions. According to the Journal of Rheumatology Supplements, “the opportunity to ablate (with autologous stem cells) severe autoimmune disease with increased safety is particularly attractive for necrotizing vasculitides, polymyositis/dermatomyositis, primary Sjögren’s syndrome, systemic juvenile arthritis, and relapsing Polychondritis.” Read more…

Relapsing Polychondritis and Cell Surgical Network

CELL SURGICAL NETWORK has developed a specific SVF deployment protocol for Polychondritis that attempts to utilize the potential immune-modulatory, anti-inflammatory, and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.